 Esophageal Neoplasms
"Esophageal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ESOPHAGUS.
| Descriptor ID |
D004938
|
| MeSH Number(s) |
C04.588.274.476.205 C04.588.443.353 C06.301.371.205 C06.405.117.430 C06.405.249.205
|
| Concept/Terms |
Esophageal Neoplasms- Esophageal Neoplasms
- Esophageal Neoplasm
- Neoplasm, Esophageal
- Esophagus Neoplasm
- Esophagus Neoplasms
- Neoplasm, Esophagus
- Neoplasms, Esophagus
- Neoplasms, Esophageal
Cancer of Esophagus- Cancer of Esophagus
- Cancer of the Esophagus
- Esophagus Cancer
- Cancer, Esophagus
- Cancers, Esophagus
- Esophagus Cancers
- Esophageal Cancer
- Cancer, Esophageal
- Cancers, Esophageal
- Esophageal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Esophageal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Esophageal Neoplasms".
This graph shows the total number of publications written about "Esophageal Neoplasms" by people in this website by year, and whether "Esophageal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 4 | 0 | 4 | | 1998 | 1 | 1 | 2 | | 1999 | 2 | 1 | 3 | | 2000 | 2 | 0 | 2 | | 2002 | 4 | 0 | 4 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 0 | 1 | | 2005 | 4 | 0 | 4 | | 2006 | 1 | 2 | 3 | | 2007 | 6 | 2 | 8 | | 2008 | 4 | 2 | 6 | | 2009 | 5 | 0 | 5 | | 2010 | 2 | 1 | 3 | | 2011 | 10 | 1 | 11 | | 2012 | 7 | 0 | 7 | | 2013 | 13 | 1 | 14 | | 2014 | 8 | 0 | 8 | | 2015 | 7 | 1 | 8 | | 2016 | 9 | 0 | 9 | | 2017 | 11 | 1 | 12 | | 2018 | 9 | 1 | 10 | | 2019 | 9 | 1 | 10 | | 2020 | 15 | 1 | 16 | | 2021 | 9 | 0 | 9 | | 2022 | 20 | 0 | 20 | | 2023 | 19 | 1 | 20 | | 2024 | 13 | 2 | 15 | | 2025 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Esophageal Neoplasms" by people in Profiles.
-
Strong Caldwell A, Milner DC, Mehta NB, Marin AI, Gill ZS, Manoharan N. MERTK INHIBITOR-ASSOCIATED RETINAL TOXICITY IN A HUMAN. Retin Cases Brief Rep. 2025 Nov 01; 19(6):807-810.
-
Stuart CM, Mott NM, Bronsert MR, Franco SR, Gleisner AL, Mungo B, McCarter MD, Randhawa SK, David EA, Mitchell JD, Meguid RA. Ongoing Implications of the COVID-19 Pandemic Environment on Esophageal Cancer Characteristics and Treatment in the United States. J Surg Oncol. 2025 Aug; 132(2):267-276.
-
Yamashita T, Fujimasa K, Otsuka K, Saito A, Kohmoto M, Motegi K, Ariyoshi T, Goto S, Yamochi T, Takimoto M, Hirasawa Y, Kubota Y, Yoshimura K, Tsunoda T, Murakami M, Aoki T. Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine Carcinoma. Anticancer Res. 2025 May; 45(5):2051-2058.
-
Balmaceda NB, Kim SS. Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma. Curr Oncol Rep. 2025 Feb; 27(2):81-94.
-
Stuart CM, Dyas AR, Yee EJ, Thielen O, Bronsert MR, Mungo B, McCarter MD, Randhawa SK, David EA, Michell JD, Meguid RA. Patient, facility, and surgical factors associated with significant delays to esophagectomy and subsequent poor outcomes: An analysis of 16,486 cases. J Thorac Cardiovasc Surg. 2025 May; 169(5):1385-1395.e5.
-
Yee EJ, Read J, Ziogas IA, Stuart CM, Olsen J, Kim SS, Mitchell JD, Meguid RA, McCarter MD, Mungo B. More May Not Be Better: Comparison of Oncologic Outcomes Following Induction Chemotherapy Plus Chemoradiation and Chemoradiation Alone for Esophageal Adenocarcinoma. J Surg Oncol. 2025 Mar; 131(4):598-606.
-
Gilbert A, Xie R, Bonnell LN, Habib RH, Worrell SG, David EA, Donahue J, Wei B. Minimally invasive versus open esophagectomy: Comparing the combined effects of smoking burden and operative approach on outcomes in esophagectomy. J Thorac Cardiovasc Surg. 2025 Mar; 169(3):777-786.e9.
-
Blasberg JD, Servais E, Thibault D, Jacobs JP, Kozower B, David E, Donahue J, Vekstein A, Kang L, Hartwig M, Jones LA, Kosinski A, Habib R, Towe C, Seder CW. Longitudinal Follow-up of Medicare Patients After Esophageal Cancer Resection in the STS Database. Ann Thorac Surg. 2025 Feb; 119(2):333-342.
-
Tippareddy C, Martinez OM, Benza AR, Bera K, Ramaiya N, Tirumani SH. From guidelines to radiology practice: navigating the 2023 ASCO guidelines for advanced gastroesophageal cancer and beyond. Abdom Radiol (NY). 2025 01; 50(1):78-93.
-
Hirasawa Y, Kubota Y, Mura E, Suzuki R, Tsurui T, Iriguchi N, Ishiguro T, Ohkuma R, Shimokawa M, Ariizumi H, Horiike A, Wada S, Ariyoshi T, Goto S, Otsuka K, Murakami M, Kiuchi Y, Yoshimura K, Hoffman RM, Tsunoda T. Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment. Anticancer Res. 2024 Aug; 44(8):3397-3407.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|